Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 31-Dec-08 8:40 PM View:  | Warner Ronald ExecVP & Chief Scientific Ofc | Alpharma, Inc. (ALO) | 29-Dec-08 | Disposition | 6,255 | -- | -- | (100%) 6.25K to 0 | |
| 31-Dec-08 8:32 PM View: | Buzinkai Donald See Remarks | Alpharma, Inc. (ALO) | 29-Dec-08 | Disposition | 494 | -- | -- | (100%) 0.49K to 0 | |
| 31-Dec-08 8:26 PM View: | Wrenn Carol See Remarks | Alpharma, Inc. (ALO) | 29-Dec-08 | Disposition | 8,971 | -- | -- | (100%) 8.97K to 0 | |
| 31-Dec-08 8:30 PM View: | Tombros Peter Director | Alpharma, Inc. (ALO) | 29-Dec-08 | Disposition | 4,818 | -- | -- | (100%) 4.82K to 0 | |
| 31-Dec-08 8:37 PM View: | Watts Peter EVP, HR and Communications | Alpharma, Inc. (ALO) | 29-Dec-08 | Disposition | 5,178 | -- | -- | (100%) 5.18K to 0 | |
| 31-Dec-08 8:31 PM View: | Mitchell Dean J President and CEO Director | Alpharma, Inc. (ALO) | 29-Dec-08 | Disposition | 13,241 | -- | -- | (100%) 13.24K to 0 | |
| 31-Dec-08 8:28 PM View: | Del Buono Joseph SEE REMARKS | Alpharma, Inc. (ALO) | 29-Dec-08 | Disposition | 937 | -- | -- | (100%) 0.94K to 0 | |
| 02-Jan-09 2:49 PM View: | Uprichard David C Director | Alpharma, Inc. (ALO) | 29-Dec-08 | Disposition | 1,500 | -- | -- | (100%) 1.5K to 0 | |
| 31-Dec-08 8:39 PM View: | Perez Ray Director | Alpharma, Inc. (ALO) | 29-Dec-08 | Disposition | 2,400 | -- | -- | (100%) 2.4K to 0 | |
| 31-Dec-08 8:30 PM View: | Campbell Jeffrey See Remarks | Alpharma, Inc. (ALO) | 29-Dec-08 | Disposition | 7,943 | -- | -- | (100%) 7.94K to 0 | |
| 31-Dec-08 8:32 PM View: | Spellman Thomas J III Exec VP, Gen Counsel & Sec | Alpharma, Inc. (ALO) | 29-Dec-08 | Disposition | 1,102 | -- | -- | (100%) 1.1K to 0 | |
| 31-Dec-08 8:37 PM View: | Ladell Peter Director | Alpharma, Inc. (ALO) | 29-Dec-08 | Disposition | 3,000 | -- | -- | (100%) 3.0K to 0 | |
| 04-Sep-08 1:27 PM View: | Buzinkai Donald VP, Controller | Alpharma, Inc. (ALO) | 02-Sep-08 | Grant | 2,801 | -- | -- | 48% 5.82K to 8.62K | |
| 26-Aug-08 7:35 PM View: | Aigner Stefan | Alpharma, Inc. (ALO) | 22-Aug-08 | Market Sale | 15,900 | $34.35 | $546,236.00 | (30%) 53.69K to 37.78K | 80% |
| 20-Aug-08 5:40 PM View: | J.P. Morgan Ventures Corp 10% Owner | Alpharma, Inc. (ALO) | 19-Aug-08 | Market Sale | 17,000 | $23.84 | $405,217.00 | (< 1%) 4.18M to 4.16M | 71% |
| 22-Aug-08 5:30 PM View: | J P Morgan Chase & Co 10% Owner | Alpharma, Inc. (ALO) | 19-Aug-08 | Market Sale | 17,446 | $23.84 | $415,946.00 | (< 1%) 8.41M to 8.39M | 71% |
| 22-Aug-08 5:30 PM View: | J P Morgan Chase & Co 10% Owner | Alpharma, Inc. (ALO) | 18-Aug-08 | Market Sale | 8,300 | $24.26 | $201,336.00 | < 1% 8.41M to 8.42M | (71%) |
| 20-Aug-08 5:40 PM View: | J.P. Morgan Ventures Corp 10% Owner | Alpharma, Inc. (ALO) | 18-Aug-08 | Market Sale | 21,000 | $24.34 | $511,089.00 | (< 1%) 4.2M to 4.18M | 71% |
| 22-Aug-08 5:30 PM View: | J P Morgan Chase & Co 10% Owner | Alpharma, Inc. (ALO) | 18-Aug-08 | Market Sale | 13,700 | $24.38 | $333,950.00 | (< 1%) 8.42M to 8.41M | 71% |
| 22-Aug-08 5:30 PM View: | J P Morgan Chase & Co 10% Owner | Alpharma, Inc. (ALO) | 15-Aug-08 | Market Purchase | 368 | $24.23 | $8,917.41 | < 1% 8.43M to 8.43M | (71%) |
| 22-Aug-08 5:30 PM View: | J P Morgan Chase & Co 10% Owner | Alpharma, Inc. (ALO) | 15-Aug-08 | Market Sale | 100 | $23.93 | $2,393.00 | < 1% 8.43M to 8.43M | (71%) |
| 22-Aug-08 5:30 PM View: | J P Morgan Chase & Co 10% Owner | Alpharma, Inc. (ALO) | 14-Aug-08 | Market Purchase | 702 | $23.89 | $16,771.00 | < 1% 8.43M to 8.43M | (71%) |
| 22-Aug-08 5:30 PM View: | J P Morgan Chase & Co 10% Owner | Alpharma, Inc. (ALO) | 12-Aug-08 | Market Sale | 50 | $24.85 | $1,242.50 | (< 1%) 8.43M to 8.43M | 72% |
| 22-Aug-08 5:30 PM View: | J P Morgan Chase & Co 10% Owner | Alpharma, Inc. (ALO) | 12-Aug-08 | Market Purchase | 400 | $24.78 | $9,914.00 | < 1% 8.43M to 8.43M | (72%) |
| 22-Aug-08 5:30 PM View: | J P Morgan Chase & Co 10% Owner | Alpharma, Inc. (ALO) | 11-Aug-08 | Market Sale | 89 | $25.00 | $2,225.00 | < 1% 8.43M to 8.43M | (72%) |
| 22-Aug-08 5:30 PM View: | J P Morgan Chase & Co 10% Owner | Alpharma, Inc. (ALO) | 11-Aug-08 | Market Purchase | 600 | $25.09 | $15,053.00 | < 1% 8.43M to 8.43M | (72%) |
| 22-Aug-08 5:30 PM View: | J P Morgan Chase & Co 10% Owner | Alpharma, Inc. (ALO) | 08-Aug-08 | Market Purchase | 100 | $23.48 | $2,348.00 | < 1% 8.43M to 8.43M | (70%) |
| 22-Aug-08 5:30 PM View: | J P Morgan Chase & Co 10% Owner | Alpharma, Inc. (ALO) | 08-Aug-08 | Market Sale | 289 | $24.29 | $7,019.81 | (< 1%) 8.43M to 8.43M | 71% |
| 22-Aug-08 5:30 PM View: | J P Morgan Chase & Co 10% Owner | Alpharma, Inc. (ALO) | 06-Aug-08 | Market Purchase | 300 | $23.27 | $6,980.01 | < 1% 8.43M to 8.43M | (70%) |
| 22-Aug-08 5:30 PM View: | J P Morgan Chase & Co 10% Owner | Alpharma, Inc. (ALO) | 05-Aug-08 | Market Purchase | 300 | $23.14 | $6,941.01 | < 1% 8.42M to 8.43M | (70%) |
| 22-Aug-08 5:30 PM View: | J P Morgan Chase & Co 10% Owner | Alpharma, Inc. (ALO) | 04-Aug-08 | Market Sale | 200 | $21.58 | $4,316.00 | (< 1%) 8.43M to 8.42M | 68% |
| 22-Aug-08 5:30 PM View: | J P Morgan Chase & Co 10% Owner | Alpharma, Inc. (ALO) | 01-Aug-08 | Market Purchase | 300 | $21.90 | $6,569.01 | < 1% 8.42M to 8.43M | (68%) |
| 22-Aug-08 5:30 PM View: | J P Morgan Chase & Co 10% Owner | Alpharma, Inc. (ALO) | 01-Aug-08 | Market Sale | 100 | $21.92 | $2,192.00 | (< 1%) 8.43M to 8.43M | 68% |
| 22-Aug-08 5:30 PM View: | J P Morgan Chase & Co 10% Owner | Alpharma, Inc. (ALO) | 31-Jul-08 | Market Sale | 200 | $22.72 | $4,544.00 | (< 1%) 8.43M to 8.42M | 69% |
| 29-Jul-08 2:26 PM View: | Shively Richard Scott SVP Pharma Commercial Ops | Alpharma, Inc. (ALO) | 25-Jul-08 | Grant | 6,559 | -- | -- | 58% 11.32K to 17.88K | |
| 16-Jun-08 11:20 AM View: | Campbell Jeffrey EVP, CFO | Alpharma, Inc. (ALO) | 13-Jun-08 | Market Purchase | 3,000 | $23.22 | $69,653.90 | 7% 43.17K to 46.17K | (70%) |
| 13-Jun-08 12:30 PM View: | Uprichard David C Director | Alpharma, Inc. (ALO) | 12-Jun-08 | Market Purchase | 500 | $23.32 | $11,660.00 | 50% 1.0K to 1.5K | (70%) |
| 12-May-08 5:35 PM View: | Tombros Peter Director | Alpharma, Inc. (ALO) | 08-May-08 | Option Exercise | 2,000 | $21.62 | $43,250.00 | 71% 2.82K to 4.82K | 17% |
| 03-Apr-08 5:53 PM View: | Carlsson Carl Ake President, API | Alpharma, Inc. (ALO) | 02-Apr-08 | Payment of Exercise | 571 | $27.33 | $15,603.10 | (2%) 33.19K to 32.62K | 75% |
| 03-Apr-08 5:53 PM View: | Carlsson Carl Ake President, API | Alpharma, Inc. (ALO) | 01-Apr-08 | Option Exercise | 11,470 | -- | -- | 53% 21.72K to 33.19K | |
| 21-Mar-08 3:31 PM View: | Carlsson Carl Ake President, API | Alpharma, Inc. (ALO) | 19-Mar-08 | Market Option Sale | 3,176 | $27.41 | $87,053.20 | (9%) 36.37K to 33.19K | 75% |
| 21-Mar-08 3:31 PM View: | Carlsson Carl Ake President, API | Alpharma, Inc. (ALO) | 19-Mar-08 | Option Exercise | 3,375 | $19.80 | $66,825.00 | 10% 33.19K to 36.57K | 39% |
| 21-Mar-08 3:31 PM View: | Carlsson Carl Ake President, API | Alpharma, Inc. (ALO) | 19-Mar-08 | Payment of Exercise | 199 | $27.41 | $5,454.53 | (< 1%) 36.57K to 36.37K | 75% |
| 10-Mar-08 10:58 AM View: | Uprichard David C Director | Alpharma, Inc. (ALO) | 07-Mar-08 | Market Purchase | 500 | $26.30 | $13,152.00 | 100% 0.5K to 1.0K | (74%) |
| 06-Mar-08 1:45 PM View: | Watts Peter EVP, HR | Alpharma, Inc. (ALO) | 05-Mar-08 | Market Purchase | 4,000 | $25.00 | $100,000.00 | 11% 37.55K to 41.55K | (72%) |
| 06-Mar-08 1:45 PM View: | Uprichard David C Director | Alpharma, Inc. (ALO) | 05-Mar-08 | Market Purchase | 500 | $25.01 | $12,507.00 | 100% 0 to 0.5K | (72%) |
| 05-Mar-08 4:11 PM View: | Aigner Stefan EVP Corporate Development | Alpharma, Inc. (ALO) | 04-Mar-08 | Payment of Exercise | 2,659 | $25.11 | $66,757.70 | (5%) 53.69K to 51.03K | 72% |
| 04-Mar-08 12:15 PM View: | Ladell Peter Director | Alpharma, Inc. (ALO) | 03-Mar-08 | Market Purchase | 3,000 | $25.14 | $75,417.00 | 100% 0 to 3.0K | (72%) |
| 05-Mar-08 4:09 PM View: | Aigner Stefan EVP Corporate Development | Alpharma, Inc. (ALO) | 03-Mar-08 | Market Purchase | 10,000 | $25.37 | $253,731.00 | 23% 43.69K to 53.69K | (73%) |
| 29-Feb-08 1:24 PM View: | Perez Ray Director | Alpharma, Inc. (ALO) | 29-Feb-08 | Market Purchase | 2,400 | $24.60 | $59,030.40 | 100% 0 to 2.4K | (72%) |
